This session will feature a fireside-style conversation between Shapiro+Raj and Akari Therapeutics focused on how AI is fundamentally reshaping leadership, decision-making, and operational agility across the pharmaceutical and biotech landscape. Rather than another high-level discussion about the promise of AI, this conversation will explore the practical realities of operating in an increasingly compressed, high-stakes environment where speed, adaptability, and intelligent use of insights are becoming competitive necessities.
The discussion will examine how emerging biotech organizations are leveraging AI to move faster with fewer resources, and why larger pharmaceutical companies may need to rethink traditional processes and organizational structures to compete in this evolving environment. Topics will include how AI is changing the way organizations gather and act on market, patient, and HCP insights, how teams are adapting workflows and behaviors around AI-enabled decision-making, and where leadership teams are seeing both friction and opportunity as these technologies mature.
Designed to be candid, practical, and interactive, the session will include audience Q&A and aims to deliver a provocative and engaging perspective that differs from a traditional market research case study presentation.
Presented by Shapiro+Raj and Akari Therapeutics
